NeuroSense Therapeutics Files U.S. Patent Application Covering Methods Of Treating Traumatic Brain Injury And Related Central Nervous System Injuries With Combination Of Ciprofloxacin And Celecoxib

NeuroSense Therapeutics has filed a U.S. patent application for methods to treat traumatic brain injury (TBI) and related central nervous system injuries using a combination of ciprofloxacin and celecoxib. The patent, if granted, could provide protection until 2047 and aims to address the significant unmet medical need for disease-modifying therapies for TBI. The company is also exploring future TBI-focused research initiatives while maintaining ALS as its primary development priority.